Award
National Institute of Allergy and Infectious Diseases 1R43AI192105-01
Optimizing immunogenicity of novel Cryptosporidium vaccine candidates
Recipient
IMMPORT THERAPEUTICS, INC.
Award Amount
$300,000.00
Ceiling
$300,000.00
Awarded
August 12, 2025
Identifier
1R43AI192105-01
Award for developing and testing novel Cryptosporidium vaccine candidates to prevent cryptosporidiosis in children, funded by NIAID with $300,000.
Description
This project involves formulation and testing of novel Cryptosporidium vaccine candidates, with a focus on mucosal and systemic immune responses in mice. The award is funded by NIAID, with a total amount of $300,000, and is part of the PA-24-245 funding opportunity. The project aims to demonstrate proof of concept for a vaccine candidate to prevent cryptosporidiosis in children.